Metabolism - Clinical and Experimental
Volume 52, Issue 9 , Pages 1147-1152 , September 2003

Effect of the alpha-adrenergic blocker, doxazosin, on endothelial function and insulin action

  • C.Hamish Courtney

      Affiliations

    • Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, United Kingdom
    • ,
  • David R McCance

      Affiliations

    • Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, United Kingdom
    • ,
  • A.Brew Atkinson

      Affiliations

    • Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, United Kingdom
    • ,
  • Jonathan Bassett

      Affiliations

    • Montalto Health Clinic, Balynahinch, Co. Down, United Kingdom
    • ,
  • Cieran N Ennis

      Affiliations

    • Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, United Kingdom
    • ,
  • Brian Sheridan

      Affiliations

    • Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, United Kingdom
    • ,
  • Patrick M Bell

      Affiliations

    • Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, United Kingdom
    • Corresponding Author InformationAddress reprint requests to Patrick M. Bell, MD, East Wing Office, Royal Victoria Hospital, Belfast, UK BT12 6BA

Received 27 September 2002 ,Accepted 22 April 2003.

References 

  1. Panza JA, Quyyumi AA, Brush JE, et al.  Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22–27
  2. Linder L, Kiowski W, Buhler FR, et al.  Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation. 1990;81:1762–1767
  3. Shen DC, Shieh SM, Fuh MT, et al.  Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab. 1988;66:580–583
  4. Ferrannini E, Buzzigoli G, Bonadonna R, et al.  Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350–357
  5. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–194
  6. Cooke J, Tsao P. Is nitric oxide an endogenous antiatherogenic molecule?. Arterioscler Thromb Vasc Biol. 1994;14:653–655
  7. Weinberger MH. Antihypertensive therapy and lipids. Evidence, mechanisms and implications. Arch Intern Med. 1985;145:1103–1105
  8. Neaton JD, Grimm RH, Prineas RJ, et al.  Treatment of mild hypertension study. Final results. JAMA. 1993;270:713–724
  9. Giorda C, Appendino M. Effects of doxazosin, a selective α 1-inhibitor, on plasma insulin and blood glucose response to a glucose tolerance test in essential hypertension. Metabolism. 1993;42:1440–1442
  10. Andersson P-E, Johansson J, Berne C, et al.  Effect of selective α1 and β1-adreno-receptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity. J Hum Hypertens. 1994;8:219–226
  11. Kageyama S, Yamamoto J, Mimura A, et al.  Doxazosin improves insulin sensitivity in hypertensive patients. Clin Ther. 1993;15:829–837
  12. McAllister AS, Atkinson AB, Johnston GD, et al.  Relationship of endothelial function to birth weight in humans. Diabetes Care. 1999;22:2061–2066
  13. Hokanson DE, Sumner DS, Strandness DEJ. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng. 1975;22:25–29
  14. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond). 1953;121:1–27
  15. Greenfield ADM, Patterson GC. Reactions of the blood vessels of the human forearm to increases in transmural pressure. J Physiol (Lond). 1954;125:508–524
  16. Neely RDG, Rooney DP, Atkinson AB, et al.  Underestimation of glucose turnover estimated using [63H]glucose tracer in non-steady state. The role of a tritiated tracer impurity. Diabetologia. 1990;33:681–687
  17. Harper R, Ennis C, Heaney AP, et al.  A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM. Diabetologia. 1995;38:853–859
  18. Somogyi M. Determination of blood sugar. J Biol Chem. 1945;160:69–73
  19. Matthews JNS, Altman DG, Campbell MJ, et al.  Analysis of serial measurements in medical research. BMJ. 1990;300:230–235
  20. Roberts DH, Tsao Y, Breckenridge M. The reproducibility of limb blood flow measurements in human volunteers at rest and after exercise by using mercury-in-silastic strain gauge plethysmography under standardized conditions. Clin Sci. 1986;70:635–638
  21. Steele R, Wall JS, De Bodo RC, et al.  Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol. 1956;187:15–25
  22. De Bodo RC, Steele R, Altszuler N, et al.  On the hormonal regulation of carbohydrate metabolism (Studies with C14 glucose). Recent Prog Horm Res. 1963;19:445–488
  23. Rooney DP, Neely RDG, Ennis CN, et al.  Insulin action and hepatic glucose cycling in essential hypertension. Metabolism. 1992;41:317–324
  24. Taddei S, Virdis A, Ghiadoni L, et al.  Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients. J Hypertens. 1998;116:447–456
  25. Taddei S, Virdis A, Ghiadoni L, et al.  Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension. 1997;30:1606–1612
  26. Lithell HOL. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care. 1991;14:203–209
  27. Hunter SJ, Harper R, Ennis CN, et al.  Effects of combination therapy with an angiotensin converting enzyme inhibitor and thiazide diuretic on insulin action in essential hypertension. J Hypertens. 1998;16:103–109
  28. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524–526
  29. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987;2:1057–1068
  30. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774–1777
  31. Gorog P, Kovacs IB. Inhibition of vascular smooth muscle cell migration by intact endothelium is nitric oxide-mediated (Interference by oxidised low density lipoproteins). J Vasc Res. 1998;35:165–169
  32. Kubes P, Suzuki M, Granger DN. Nitric oxide (An endogenous modulator of leukocyte adhesion). Proc Natl Acad Sci USA. 1991;88:4651–4655
  33. Seljeflot I, Arnesen H, Andersen P, et al.  Effects of doxazosin and atenolol on circulating endothelin-1 and von Willebrand factor in hypertensive middle-aged men. J Cardiovasc Pharmacol. 1999;34:584–588
  34. Tojo A, Kobayashi N, Kimura K, et al.  Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney. Kidney Int. 1996;49:S138–S140
  35. Chait A, Gilmore M, Kawamura M. Inhibition of low density lipoprotein oxidation in vitro by the 6- and 7-hydroxy-metabolites of doxazosin, an α 1-adrenergic antihypertensive agent. Am J Hypertens. 1994;7:159–167
  36. Tzemos N, Lim PO, MacDonald TM. Nebivolol reverses endothelial dysfunction in essential hypertension. Circulation. 2001;104:511–514
  37. Rooney DP, Edgar JDM, Sheridan B, et al.  The effects of low dose insulin infusions on the renin angiotensin and sympathetic nervous systems in normal man. Eur J Clin Invest. 1991;21:430–435
  38. De Fronzo RA, Cooke CR, Andres R, et al.  The effect of insulin on renal handling of sodium, potassium, calcium and phosphate in man. J Clin Invest. 1975;55:845–855
  39. Stout RW. Insulin and atheroma (20 year perspective). Diabetes Care. 1990;13:631–654
  40. Fuller JH, Shipley MJ, Rose G, et al.  Coronary heart disease risk and impaired glucose tolerance. Lancet. 1980;1:1373–1376
  41. Lithell H, Pollare T, Vessby B. Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients. Blood Press. 1992;1:92–101
  42. de Courten M, Ferrari P, Schneider M, et al.  Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension. Eur J Clin Pharmacol. 1993;44:457–462
  43. UKPDS Study Group . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ. 1998;317:703–713
  44. Giorda C, Appendino M, Mason MG, et al.  Alpha 1-blocker doxazosin improves peripheral insulin sensitivity in diabetic hypertensive patients. Metabolism. 1995;44:673–676
  45. Giordano M, Matsuda M, Sanders L, et al.  Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists and α-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes. 1995;44:665–671
  46. Baron AD, Steinberg HO, Chaker H, et al.  Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest. 1995;96:786–792
  47. Utriainen T, Makimattila S, Virkamaki A, et al.  Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects. Diabetologia. 1996;39:1477–1482
  48. Utriainen T, Malmstrom R, Makimattila S, et al.  Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia. 1995;38:555–564
  49. Hunter SJ, Harper R, Ennis CN, et al.  Skeletal muscle blood flow is not a determinant of insulin resistance in essential hypertension. J Hypertens. 1997;15:73–77

☆ Supported by a Royal Victoria Hospital Research Fellowship (to C.H.C.), Royal Victoria Hospital Metabolic Unit Research Fund, and Pfizer UK (to C.H.C. and P.M.B.).

PII: S0026-0495(03)00190-2

doi: 10.1016/S0026-0495(03)00190-2

Metabolism - Clinical and Experimental
Volume 52, Issue 9 , Pages 1147-1152 , September 2003

Article Tools

* Image Usage & Resolution